In last trading session, Milestone Pharmaceuticals Inc (NASDAQ:MIST) saw 2.36 million shares changing hands with its beta currently measuring 1.02. Company’s recent per share price level of $2.03 trading at $0.1 or 5.18% at ring of the bell on the day assigns it a market valuation of $108.25M. That closing price of MIST’s stock is at a discount of -35.47% from its 52-week high price of $2.75 and is indicating a premium of 44.83% from its 52-week low price of $1.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.67 million shares which gives us an average trading volume of 895.13K if we extend that period to 3-months.
For Milestone Pharmaceuticals Inc (MIST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Upright in the green during last session for gaining 5.18%, in the last five days MIST remained trading in the green while hitting it’s week-highest on Thursday, 03/13/25 when the stock touched $2.03 price level, adding 6.45% to its value on the day. Milestone Pharmaceuticals Inc’s shares saw a change of -13.98% in year-to-date performance and have moved 6.84% in past 5-day. Milestone Pharmaceuticals Inc (NASDAQ:MIST) showed a performance of -7.31% in past 30-days. Number of shares sold short was 0.74 million shares which calculate 0.71 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 79.7% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -392.61% in reaching the projected high whereas dropping to the targeted low would mean a loss of -392.61% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -7.22% during past 5 years.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
Insiders are in possession of 0.65% of company’s total shares while institution are holding 46.28 percent of that, with stock having share float percentage of 46.59%. Investors also watch the number of corporate investors in a company very closely, which is 46.28% institutions for Milestone Pharmaceuticals Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at MIST for having 4.97 million shares of worth $6.56 million. And as of 2024-06-30, it was holding 9.9119 of the company’s outstanding shares.
The second largest institutional holder is RTW INVESTMENTS, LP, which was holding about 3.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.9211 of outstanding shares, having a total worth of $4.3 million.
On the other hand, Fidelity NASDAQ Composite Index Fund and SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 19.87 shares of worth $40340.0 or 0.04% of the total outstanding shares. The later fund manager was in possession of 19.12 shares on Dec 31, 2024 , making its stake of worth around $38807.0 in the company or a holder of 0.04% of company’s stock.
